Literature DB >> 29067655

Characterization of the Inflammatory Response in Dystrophic Muscle Using Flow Cytometry.

Jenna M Kastenschmidt1,2, Ileen Avetyan1,2, S A Villalta3,4.   

Abstract

Although mutations of the dystrophin gene are the causative defect in Duchenne muscular dystrophy (DMD) patients, secondary disease processes such as inflammation contribute greatly to the pathogenesis of DMD. Genetic and histological studies have shown that distinct facets of the immune system promote muscle degeneration or regeneration during muscular dystrophy through mechanisms that are only beginning to be defined. Although histological methods have allowed the enumeration and localization of immune cells within dystrophic muscle, they are limited in their ability to assess the full spectrum of phenotypic states of an immune cell population and its functional characteristics. This chapter highlights flow cytometry methods for the isolation and functional study of immune cell populations from muscle of the mdx mouse model of DMD. We include a detailed description of preparing single-cell suspensions of dystrophic muscle that maintain the integrity of cell-surface markers used to identify macrophages, eosinophils, group 2 innate lymphoid cells, and regulatory T cells. This method complements the battery of histological assays that are currently used to study the role of inflammation in muscular dystrophy, and provides a platform capable of being integrated with multiple downstream methodologies for the mechanistic study of immunity in muscle degenerative diseases.

Entities:  

Keywords:  Eosinophils; FACS; Flow cytometry; ILC2; Immune system; Inflammatory cells; Macrophages; Muscle inflammation; Muscular dystrophy; Tregs; mdx

Mesh:

Substances:

Year:  2018        PMID: 29067655      PMCID: PMC5920697          DOI: 10.1007/978-1-4939-7374-3_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  30 in total

Review 1.  The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.

Authors:  Qizhi Tang; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2008-03       Impact factor: 25.606

2.  Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect.

Authors:  Kevin M Flanigan; Katie Campbell; Laurence Viollet; Wei Wang; Ana Maria Gomez; Christopher M Walker; Jerry R Mendell
Journal:  Hum Gene Ther       Date:  2013-09       Impact factor: 5.695

3.  Highly Dynamic Transcriptional Signature of Distinct Macrophage Subsets during Sterile Inflammation, Resolution, and Tissue Repair.

Authors:  Tamas Varga; Rémi Mounier; Attila Horvath; Sylvain Cuvellier; Florent Dumont; Szilard Poliska; Hamida Ardjoune; Gaëtan Juban; Laszlo Nagy; Bénédicte Chazaud
Journal:  J Immunol       Date:  2016-04-29       Impact factor: 5.422

4.  Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression.

Authors:  Mario Pescatori; Aldobrando Broccolini; Carlo Minetti; Enrico Bertini; Claudio Bruno; Adele D'amico; Camilla Bernardini; Massimiliano Mirabella; Gabriella Silvestri; Vincenzo Giglio; Anna Modoni; Marina Pedemonte; Giorgio Tasca; Giuliana Galluzzi; Eugenio Mercuri; Pietro A Tonali; Enzo Ricci
Journal:  FASEB J       Date:  2007-01-30       Impact factor: 5.191

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy.

Authors:  S Armando Villalta; Wendy Rosenthal; Leonel Martinez; Amanjot Kaur; Tim Sparwasser; James G Tidball; Marta Margeta; Melissa J Spencer; Jeffrey A Bluestone
Journal:  Sci Transl Med       Date:  2014-10-15       Impact factor: 17.956

7.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

8.  Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy.

Authors:  R M McDouall; M J Dunn; V Dubowitz
Journal:  J Neurol Sci       Date:  1990-11       Impact factor: 3.181

Review 9.  Interleukin-10: new perspectives on an old cytokine.

Authors:  David M Mosser; Xia Zhang
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

Review 10.  Glucocorticoid corticosteroids for Duchenne muscular dystrophy.

Authors:  A Y Manzur; T Kuntzer; M Pike; A Swan
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more
  5 in total

1.  FACS isolation of live mouse eosinophils at high purity via a protocol that does not target Siglec F.

Authors:  Wendy E Geslewitz; Caroline M Percopo; Helene F Rosenberg
Journal:  J Immunol Methods       Date:  2017-12-16       Impact factor: 2.303

2.  Early Inflammation in Muscular Dystrophy Differs between Limb and Respiratory Muscles and Increases with Dystrophic Severity.

Authors:  Zachary M Howard; Jeovanna Lowe; Anton J Blatnik; Deztani Roberts; Arthur H M Burghes; Shyam S Bansal; Jill A Rafael-Fortney
Journal:  Am J Pathol       Date:  2021-01-23       Impact factor: 4.307

3.  A stromal progenitor and ILC2 niche promotes muscle eosinophilia and fibrosis-associated gene expression.

Authors:  Jenna M Kastenschmidt; Gerald Coulis; Philip K Farahat; Phillip Pham; Rodolfo Rios; Therese T Cristal; Ali H Mannaa; Rachel E Ayer; Rayan Yahia; Archis A Deshpande; Brandon S Hughes; Adam K Savage; Carlee R Giesige; Scott Q Harper; Richard M Locksley; Tahseen Mozaffar; S Armando Villalta
Journal:  Cell Rep       Date:  2021-04-13       Impact factor: 9.423

Review 4.  Mechanisms Regulating Muscle Regeneration: Insights into the Interrelated and Time-Dependent Phases of Tissue Healing.

Authors:  Laura Forcina; Marianna Cosentino; Antonio Musarò
Journal:  Cells       Date:  2020-05-22       Impact factor: 6.600

5.  The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and Mice.

Authors:  Rylie M Hightower; Andrea L Reid; Devin E Gibbs; Yimin Wang; Jeffrey J Widrick; Louis M Kunkel; Jenna M Kastenschmidt; S Armando Villalta; Thomas van Groen; Hua Chang; Savanna Gornisiewicz; Yosef Landesman; Sharon Tamir; Matthew S Alexander
Journal:  Mol Ther       Date:  2019-09-03       Impact factor: 11.454

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.